Suppression of G-CSF-mediated Stat signalling by IL-3

被引:13
作者
Steinman, RA
Iro, A
机构
[1] Univ Pittsburgh, Pittsburgh Canc Inst, Pittsburgh, PA 15213 USA
[2] Univ Pittsburgh, Sch Med, Div Hematol Oncol, Pittsburgh, PA 15260 USA
关键词
differentiation; Stat; G-CSF; interleukin-3; abl oncogene;
D O I
10.1038/sj.leu.2401253
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
G-CSF-induced myeloid differentiation of 32Dcl3 murine myeloblast cells is antagonized by concurrent exposure to interleukin-3 (IL-3) or by oncogenic transformation of 32Dcl3 by src- or abl-oncogenes which render the cells IL-3-independent. Recent reports have linked G-CSF-mediated differentiation to the ability of G-CSF to activate Stat3. We hypothesized that IL-3 suppresses 32Dcl3 differentiation in part through disruption of G-CSF-Stat signalling. We report that IL-3 inhibited the ability of G-CSF to induce Stat3 DNA binding. Moreover, we find that G-CSF activation of Stat3 binding to DNA is biphasic, peaking at 15-30 min and again at 6-8 h; both peaks are inhibited by IL-3. Transformation of 32Dcl3 cells by the v-abl oncogene leads to constitutive Stat3 activation and distinctive Stat-DNA-binding patterns which are not affected by G-CSF. Cross-modulation of Stat pathway signalling could be a physiologic mechanism for establishing a hierarchy of growth factor effects upon a cell exposed at once to multiple cytokines.
引用
收藏
页码:54 / 61
页数:8
相关论文
共 41 条
[1]  
ANDERSON SM, 1990, ONCOGENE, V5, P317
[2]   PROLIFERATIVE BUT NOT NONPROLIFERATIVE RESPONSES TO GRANULOCYTE-COLONY-STIMULATING FACTOR ARE ASSOCIATED WITH RAPID ACTIVATION OF THE P21(RAS)/MAP KINASE SIGNALING PATHWAY [J].
BASHEY, A ;
HEALY, L ;
MARSHALL, CJ .
BLOOD, 1994, 83 (04) :949-957
[3]  
BOLOVENTA C, 1996, FEBS LETT, V386, P239
[4]   Stat3 activation is required for cellular transformation by v-src [J].
Bromberg, JF ;
Horvath, CM ;
Besser, D ;
Lathem, WW ;
Darnell, JE .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (05) :2553-2558
[5]   STAT3 beta, a splice variant of transcription factor STAT3, is a dominant negative regulator of transcription [J].
Caldenhoven, E ;
vanDijk, TB ;
Solari, R ;
Armstrong, J ;
Raaijmakers, JAM ;
Lammers, JWJ ;
Koenderman, L ;
deGroot, RP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (22) :13221-13227
[6]  
CARLESSO N, 1994, ONCOGENE, V9, P149
[7]   Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl [J].
Carlesso, N ;
Frank, DA ;
Griffin, JD .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (03) :811-820
[8]   Granulocyte colony-stimulating factor activation of Stat3 alpha and Stat3 beta in immature normal and leukemic human myeloid cells [J].
Chakraborty, A ;
White, SM ;
Schaefer, TS ;
Ball, ED ;
Dyer, KF ;
Tweardy, DJ .
BLOOD, 1996, 88 (07) :2442-2449
[9]   Src kinases and not JAKs activate STATs during IL-3 induced myeloid cell proliferation [J].
Chaturvedi, P ;
Reddy, MVR ;
Reddy, EP .
ONCOGENE, 1998, 16 (13) :1749-1758
[10]   TYROSINE KINASE ONCOGENES ABROGATE INTERLEUKIN-3 DEPENDENCE OF MURINE MYELOID CELLS THROUGH SIGNALING PATHWAYS INVOLVING C-MYC - CONDITIONAL REGULATION OF C-MYC TRANSCRIPTION BY TEMPERATURE-SENSITIVE V-ABL [J].
CLEVELAND, JL ;
DEAN, M ;
ROSENBERG, N ;
WANG, JYJ ;
RAPP, UR .
MOLECULAR AND CELLULAR BIOLOGY, 1989, 9 (12) :5685-5695